Medical shrinkage of endometriomas with aromatase inhibition and progestin add-back

In: Fertility and Sterility · 2013 · vol. 100(3) , pp. S371 · doi:10.1016/j.fertnstert.2013.07.797 · W2019203858
OA: closed CC0
⚙ AI-generated summary by qwen3.7-flash, 2026-08-22 ⓘ

This paper investigates the medical shrinkage of endometriomas using aromatase inhibition combined with progestin add-back therapy.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
unpaywall
last seen: 2026-09-17T06:32:46.214484+00:00
License: CC0 · commercial use OK